Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB681323 in Neuropathic Pain Following Nerve Trauma
NCT00390845Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2006
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of dilmapimod in neuropathic pain, sponsored by GSK. Started Aug 2006; status: completed.
02
Drugs
dilmapimod
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT00390845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00390845.